1.
Neurol Neuroimmunol Neuroinflamm
; 7(2)2020 01.
Article
En
| MEDLINE
| ID: mdl-31915266
Alemtuzumab/adverse effects , Chronic Urticaria/chemically induced , Immunologic Factors/adverse effects , Multiple Sclerosis/drug therapy , Adult , Anti-Allergic Agents/administration & dosage , Cetirizine/administration & dosage , Chronic Urticaria/drug therapy , Female , Glucocorticoids/administration & dosage , Humans , Omalizumab/administration & dosage , Prednisolone/administration & dosage